Karyopharm Therapeutics, $KPTI, is emerging from an 11-month base. I’m always intrigued by bases because typically a prolonged period of contraction leads to an extended period of expansion. We have covered bases extensively here (SEE BELOW) on the blog, and it’s my favorite set up.
Stan Weinstein, the author of Secrets For Profiting In Bull and Bear Markets, has a great definition the “basing area,” specifically the one’s that are formed after being down for several months.
The Basing Area: “After XYZ has been declining for several months, it eventually will lose downside momentum and start to trend sideways. What’s actually taking place is that buyers and sellers are starting to move into equilibrium, whereas previously the sellers were far stronger, which is why the stock had plummeted. Volume will usually lessen–dry up–as a base forms. But often volume will start to expand late stage 1, even though prices remain little changed. This is an indication that dumping of the stock by disgruntled owners is no longer driving down the price. The buyers who are moving in to take the stock off their hands are not demanding any significant price concession.”
That’s exactly what is happening with $KPTI, it has been going sideways for 11-months and now you see a pattern of higher lows. Very simply, the buyers are no longer waiting to buy the stock near the bottom of the base, they want it now, they see greener pastures ahead.
This information is issued solely for informational and educational purposes and does not constitute an offer to sell or a solicitation of an offer to buy securities. None of the information contained in this blog constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. From time to time, the content creator or its affiliates may hold positions or other interests in securities mentioned in this blog. The stocks presented are not to be considered a recommendation to buy any stock. This material does not take into account your particular investment objectives. Investors should consult their own financial or investment adviser before trading or acting upon any information provided. Past performance is not indicative of future results.